Tirzepatide

Tirzepatide is a synthetic peptide that functions as a dual agonist, activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism makes it a unique research compound in metabolic studies. Researchers investigate its effects on glucose homeostasis, insulin secretion, and energy metabolism in laboratory settings.

Scientists study Tirzepatide for its potential effects on metabolic pathways, particularly its dual receptor activation mechanism. Research focuses on how GIP and GLP-1 receptor stimulation influences insulin sensitivity, glucagon suppression, gastric emptying, and appetite regulation. Studies examine its impact on body composition, lipid metabolism, and cellular energy utilization in various research models.